These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34684026)

  • 1. Development of Multi-Compartment 3D-Printed Tablets Loaded with Self-Nanoemulsified Formulations of Various Drugs: A New Strategy for Personalized Medicine.
    Ahmed TA; Felimban RI; Tayeb HH; Rizg WY; Alnadwi FH; Alotaibi HA; Alhakamy NA; Abd-Allah FI; Mohamed GA; Zidan AS; El-Say KM
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34684026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of 3D-Printed, Liquisolid and Directly Compressed Glimepiride Tablets, Loaded with Black Seed Oil Self-Nanoemulsifying Drug Delivery System: In Vitro and In Vivo Characterization.
    Ahmed TA; Alotaibi HA; Alharbi WS; Safo MK; El-Say KM
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pairing 3D-Printing with Nanotechnology to Manage Metabolic Syndrome.
    El-Say KM; Felimban RI; Tayeb HH; Chaudhary AG; Omar AM; Rizg WY; Alnadwi FH; Abd-Allah FI; Ahmed TA
    Int J Nanomedicine; 2022; 17():1783-1801. PubMed ID: 35479768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior.
    Ahmed TA; El-Say KM; Hosny KM; Aljaeid BM
    Drug Dev Ind Pharm; 2018 Apr; 44(4):652-661. PubMed ID: 29139305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats.
    Ahmed TA; Alotaibi HA; Almehmady AM; Safo MK; El-Say KM
    Nanomaterials (Basel); 2022 Nov; 12(22):. PubMed ID: 36432252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system.
    Kamel AO; Mahmoud AA
    J Biomed Nanotechnol; 2013 Jan; 9(1):26-39. PubMed ID: 23627065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating valsartan in sesame oil enriched self-nanoemulsifying system-loaded liquisolid tablets to improve its bioavailability.
    El-Say KM; Alamri SH; Alsulimani HH; Alharbi WS; Omar AM; Safo MK; Ahmed TA
    Int J Pharm; 2023 May; 639():122966. PubMed ID: 37084835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid super saturated self-nanoemulsifying drug delivery system (sat-SNEDDS) as a promising alternative to conventional SNEDDS for improvement rosuvastatin calcium oral bioavailability.
    Abo Enin HA; Abdel-Bar HM
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1513-1521. PubMed ID: 27564321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability.
    Alhasani KF; Kazi M; Ibrahim MA; Shahba AA; Alanazi FK
    Int J Nanomedicine; 2019; 14():5435-5448. PubMed ID: 31409997
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.
    Patel J; Dhingani A; Garala K; Raval M; Sheth N
    Drug Deliv; 2014 Sep; 21(6):412-35. PubMed ID: 24215334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin.
    Salem HF; Kharshoum RM; Halawa AKA; Naguib DM
    J Liposome Res; 2018 Jun; 28(2):149-160. PubMed ID: 28287014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of various solid carriers and spray drying on pre/post compression properties of solid SNEDDS loaded with glimepiride: in vitro-ex vivo evaluation and cytotoxicity assessment.
    Rajesh SY; Singh SK; Pandey NK; Sharma P; Bawa P; Kumar B; Gulati M; Jain SK; Gowthamarajan K; Singh S
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1056-1069. PubMed ID: 29360412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation.
    Nasr A; Gardouh A; Ghorab M
    Pharmaceutics; 2016 Jun; 8(3):. PubMed ID: 27355963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.
    Balakumar K; Raghavan CV; selvan NT; prasad RH; Abdu S
    Colloids Surf B Biointerfaces; 2013 Dec; 112():337-43. PubMed ID: 24012665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Solubility and Bioavailability of Rosuvastatin into Self Nanoemulsifying Drug Delivery System.
    Karasulu HY; Gundogdu E; Turk UO; Turgay T; Apaydin S; Simsir IY; Yilmaz C; Karasulu E
    Curr Drug Deliv; 2018; 15(7):1072-1082. PubMed ID: 29484996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.
    Hashem FM; Al-Sawahli MM; Nasr M; Ahmed OA
    Drug Des Devel Ther; 2015; 9():3141-52. PubMed ID: 26150693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetic study for the effect of glimepiride matrix tablets developed by quality by design concept.
    Ahmed TA; Suhail MAA; Hosny KM; Abd-Allah FI
    Drug Dev Ind Pharm; 2018 Jan; 44(1):66-81. PubMed ID: 28831818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.